JP2008507261A - 肺癌診断のための新規のヌクレオチド配列およびアミノ酸配列、ならびにそのアッセイおよび使用方法 - Google Patents

肺癌診断のための新規のヌクレオチド配列およびアミノ酸配列、ならびにそのアッセイおよび使用方法 Download PDF

Info

Publication number
JP2008507261A
JP2008507261A JP2007519922A JP2007519922A JP2008507261A JP 2008507261 A JP2008507261 A JP 2008507261A JP 2007519922 A JP2007519922 A JP 2007519922A JP 2007519922 A JP2007519922 A JP 2007519922A JP 2008507261 A JP2008507261 A JP 2008507261A
Authority
JP
Japan
Prior art keywords
pea
amino acid
amino acids
acid sequence
isolated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007519922A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008507261A5 (de
Inventor
ポロック，サラ
レビン，ズリット
ノヴィク，アミト
ダハリ，ドゥビル
ソレク，ロテム
トポリク，アミル
サメア−グリーンワルド，シャ−リー
セラ−タヴォル，オスナット
ディベル，アレキサンダー
コジョカル，ガッド，エス．
アヤロン−ソファー，マイケル
ワラチ，シラ
アキヴァ，ピンチャス
ケレン，ナオミ
シェメシ，ロネン
Original Assignee
コンピュゲン ユーエスエイ，インク．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by コンピュゲン ユーエスエイ，インク． filed Critical コンピュゲン ユーエスエイ，インク．
Priority claimed from US11/051,720 external-priority patent/US7569662B2/en
Publication of JP2008507261A publication Critical patent/JP2008507261A/ja
Publication of JP2008507261A5 publication Critical patent/JP2008507261A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2007519922A 2004-01-27 2005-01-27 肺癌診断のための新規のヌクレオチド配列およびアミノ酸配列、ならびにそのアッセイおよび使用方法 Pending JP2008507261A (ja)

Applications Claiming Priority (32)

Application Number Priority Date Filing Date Title
US53912904P 2004-01-27 2004-01-27
US53912804P 2004-01-27 2004-01-27
US58981504P 2004-07-22 2004-07-22
US60730704P 2004-09-07 2004-09-07
US62067704P 2004-10-22 2004-10-22
US62087404P 2004-10-22 2004-10-22
US62100404P 2004-10-22 2004-10-22
US62092404P 2004-10-22 2004-10-22
US62097404P 2004-10-22 2004-10-22
US62065604P 2004-10-22 2004-10-22
US62091804P 2004-10-22 2004-10-22
US62091704P 2004-10-22 2004-10-22
US62091604P 2004-10-22 2004-10-22
US62085304P 2004-10-22 2004-10-22
US62086804P 2004-10-22 2004-10-22
US62097504P 2004-10-22 2004-10-22
US62113104P 2004-10-25 2004-10-25
US62105304P 2004-10-25 2004-10-25
US62811104P 2004-11-17 2004-11-17
US62810104P 2004-11-17 2004-11-17
US62816704P 2004-11-17 2004-11-17
US62825104P 2004-11-17 2004-11-17
US62811204P 2004-11-17 2004-11-17
US62817804P 2004-11-17 2004-11-17
US62812304P 2004-11-17 2004-11-17
US62813404P 2004-11-17 2004-11-17
US62818904P 2004-11-17 2004-11-17
US62814504P 2004-11-17 2004-11-17
US62815604P 2004-11-17 2004-11-17
US63407504P 2004-12-08 2004-12-08
PCT/IB2005/004037 WO2006131783A2 (en) 2004-01-27 2005-01-27 Polynucleotides, polypeptides, and diagnosing lung cancer
US11/051,720 US7569662B2 (en) 2004-01-27 2005-01-27 Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer

Publications (2)

Publication Number Publication Date
JP2008507261A true JP2008507261A (ja) 2008-03-13
JP2008507261A5 JP2008507261A5 (de) 2008-04-24

Family

ID=37450522

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007519922A Pending JP2008507261A (ja) 2004-01-27 2005-01-27 肺癌診断のための新規のヌクレオチド配列およびアミノ酸配列、ならびにそのアッセイおよび使用方法

Country Status (5)

Country Link
EP (1) EP1774046A4 (de)
JP (1) JP2008507261A (de)
AU (1) AU2005320352A1 (de)
CA (1) CA2555509A1 (de)
WO (1) WO2006131783A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101403019B1 (ko) 2013-02-25 2014-06-03 서울대학교산학협력단 폐암 진단용 마커

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2275547B1 (de) 2004-12-13 2014-03-05 Alethia Biotherapeutics Inc. Am Prozess der Knochengeweberemodellierung beteiligte Polynukleotid- und Polypeptidsequenzen
KR20210060670A (ko) 2008-12-09 2021-05-26 제넨테크, 인크. 항-ｐｄ-ｌ１ 항체 및 ｔ 세포 기능을 향상시키기 위한 그의 용도
CN114804550B (zh) * 2022-06-10 2023-06-02 安徽新宇环保科技股份有限公司 一种基于神经网络模型的污水处理调控系统
CN115894942B (zh) * 2022-11-07 2024-01-12 同济大学 聚己内酯修饰的超支化梳型聚赖氨酸及应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004514A2 (en) * 2000-07-11 2002-01-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
WO2002086443A2 (en) * 2001-04-18 2002-10-31 Protein Design Labs, Inc Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
WO2003037267A2 (en) * 2001-10-29 2003-05-08 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
WO2003097666A2 (en) * 2002-05-16 2003-11-27 Euro-Celtique, S.A. Use of gastrin releasing peptide (grp) and its receptor in cancer screening

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID23661A (id) * 1997-08-14 2000-05-11 Novo Nordisk As Komposisi antimixroba yang mengandung haloperoksidase sumber halida dan sumber amonium
AU2002322280A1 (en) * 2001-06-21 2003-01-21 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004514A2 (en) * 2000-07-11 2002-01-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
WO2002086443A2 (en) * 2001-04-18 2002-10-31 Protein Design Labs, Inc Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
WO2003037267A2 (en) * 2001-10-29 2003-05-08 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
WO2003097666A2 (en) * 2002-05-16 2003-11-27 Euro-Celtique, S.A. Use of gastrin releasing peptide (grp) and its receptor in cancer screening

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101403019B1 (ko) 2013-02-25 2014-06-03 서울대학교산학협력단 폐암 진단용 마커

Also Published As

Publication number Publication date
CA2555509A1 (en) 2005-07-27
AU2005320352A8 (en) 2009-04-30
WO2006131783A2 (en) 2006-12-14
EP1774046A2 (de) 2007-04-18
AU2005320352A2 (en) 2006-08-31
EP1774046A4 (de) 2010-09-15
WO2006131783A3 (en) 2009-08-27
AU2005320352A1 (en) 2006-08-31

Similar Documents

Publication Publication Date Title
US7368548B2 (en) Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer
US7569662B2 (en) Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
US20060147946A1 (en) Novel calcium channel variants and methods of use thereof
US7332569B2 (en) Brain natriuretic peptide spliced variant
JP2003518920A (ja) 新規なヒト遺伝子および遺伝子発現産物
AU2005207886A1 (en) Novel brain natriuretic peptide variants and methods of use thereof
KR20080080525A (ko) 유전자 전사에 대한 ｆｇｆｒ３의 억제제의 효과
EP1105474A2 (de) Menschliche gene und genexpressionsprodukte v
CA2840472A1 (en) Methods and compositions for the treatment and diagnosis of bladder cancer
JP2011254830A (ja) 結腸癌に関するポリヌクレオチド
US20060263786A1 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of colon cancer
JP2008507261A (ja) 肺癌診断のための新規のヌクレオチド配列およびアミノ酸配列、ならびにそのアッセイおよび使用方法
US20090215046A1 (en) Novel nucleotide and amino acid sequences, and assays methods of use thereof for diagnosis of colon cancer
US20050186600A1 (en) Polynucleotides encoding novel UbcH10 polypeptides and kits and methods using same
US7528243B2 (en) Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
EP1721257A2 (de) Differentieller ausdruck von markierungen beim ovarialkrebs
EP1749025A2 (de) Neue nukleotid- und aminosäuresequenzen sowie tests und verwendungsverfahren dafür zur diagnose von kolonkarzinom
WO2005072050A2 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
JP2007525213A (ja) 新規の脳性ナトリウム利尿ペプチドの変異体及びその利用方法
US20100124786A1 (en) Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of use Thereof for Diagnosis of Ovarian Cancer
WO2005107364A2 (en) Polynucleotide, polypeptides, and diagnostic methods
EP1735468A2 (de) Neue nukleotid- und aminosäuresequenzen sowie tests und verfahren zu deren verwendung bei der diagnose von prostatakrebs
WO2006021874A2 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer
JP2007520217A (ja) 新規ヌクレオチドおよびアミノ酸配列、ならびにそれを用いた乳癌診断のためのアッセイおよび使用方法
AU2005276208A1 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer

Legal Events

Date Code Title Description
RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20071129

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080122

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080122

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100817

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20100907

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110208